Biolife Sciences (Biolife Sciences) FCF Margin % : -6.01% (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biolife Sciences's Free Cash Flow for the three months ended in May. 2008 was $-0.11 Mil. Biolife Sciences's Revenue for the three months ended in May. 2008 was $1.80 Mil. Therefore, Biolife Sciences's FCF Margin % for the quarter that ended in May. 2008 was -6.01%.

As of today, Biolife Sciences's current FCF Yield % is 0.00%.

The historical rank and industry rank for Biolife Sciences's FCF Margin % or its related term are showing as below:

BLFE' s FCF Margin % Range Over the Past 10 Years
Min: -11.04 Med: 0 Max: 0
Current: -11.04

BLFE's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -7.055 vs BLFE: -11.04

Biolife Sciences FCF Margin % Historical Data

The historical data trend for Biolife Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences FCF Margin % Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

FCF Margin %

-400.00

-0.98

-3.31

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
FCF Margin %	Get a 7-Day Free Trial										1.38	-11.50	-6.56	-23.46	-6.01

Competitive Comparison of Biolife Sciences's FCF Margin %

For the Medical Instruments & Supplies subindustry, Biolife Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biolife Sciences's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's FCF Margin % falls into.

Biolife Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biolife Sciences's FCF Margin for the fiscal year that ended in Nov. 2007 is calculated as

FCF Margin	=	Free Cash Flow (A: Nov. 2007 )	/	Revenue (A: Nov. 2007 )
	=	-0.285	/	8.603
	=	-3.31 %

Biolife Sciences's FCF Margin for the quarter that ended in May. 2008 is calculated as

FCF Margin	=	Free Cash Flow (Q: May. 2008 )	/	Revenue (Q: May. 2008 )
	=	-0.108	/	1.798
	=	-6.01 %

Biolife Sciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020